The implanting clinician explained to the clinical representative the leads were not visible.However, a very small portion of something blue was visible, which the implanting clinician believes is the suture eroding, not the stimulator.The clinical representative confirmed that the implant procedures were completed in accordance with the product instructions for use.The patient reported receiving therapy.The implanting clinician inspected the site and decided not to revise the suture.Based on this information, the device erosion was not confirmed/replicated, there is no evidence that product did not meet specification and the stimulator is used for treatment of pain.The cause of the suture erosion is unknown/no problem found; the device did not erode.Design fmea 06-0537 and hra 06-0524 was reviewed and device erosion is a known issue with mitigation controls in place to reduce risk as far as possible therefore, no capa is required.Stimwave's global device erosion rate: 0.32% and the impact is important and the frequency is occasionally.
|